Chapman University’s Dr. Jerika Lam and CSHP‘s CEO Dr. Loriann De Martini co-published “A mixed methods evaluation of pharmacists’ readiness to provide long-acting injectable HIV pre-exposure prophylaxis in California” in the Journal of Acquired Immune Deficiency Syndromes (JAIDS). The study investigated the underlying causes for why HIV prevention medication, pre-exposure prophylaxis (PrEP), isn’t widely used
Awards and Recognitions The Chapman/SCAN/Providence PGY1 Managed Care Residency was selected by the Greater Irvine Chamber for the Healthcare in Collaboration Award. An equal partnership between Chapman, SCAN Health Plan, and Providence Medical Foundation, the award was received by Dr. Jelena Lewis and accompanied by other Chapman representatives, including Dean Dr. Ren Ostrom, Associate Deans
Gilead’s NOVA RFP has awarded Dr. Jerika Lam $82,871 to fund a clinical trial study on HIV prevention to produce outcomes that will help put an end to the HIV epidemic- A virus that has taken an estimated 40M lives globally. Dr. Lam’s award will fund her proposal, “Exploring barriers and facilitators to pharmacy-based HIV